Insights

More Articles Back to Article

New pregnancy prevention drug gains FDA nod

Mayne Pharma has gained the FDA's approval for its contraceptive Nextstellis, or drospirenone and estetrol, which is expected to become commercially available by the end of June. eMPR (4/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!